Related Experiment Video
Updated: Nov 3, 2025

Author Spotlight: Developing Innovative Therapeutic Strategies for Hemorrhagic Shock Research
Published on: March 22, 2024
Correlation between hemorrhage risk prediction score and severe maternal morbidity
Jaclyn M Phillips1, Francis Hacker1, Lara Lemon2
1Department of Obstetrics, Gynecology, and Reproductive Sciences, University of Pittsburgh Medical Center Magee-Womens Hospital, University of Pittsburgh School of Medicine, Pittsburgh, PA (Drs Phillips, Hacker, Lemon, and Simhan).
The California Maternal Quality Care Collaborative hemorrhage risk score effectively predicts severe maternal morbidity, including non-transfusion-related events. High-risk patients face significantly higher morbidity, indicating a need for improved interventions beyond risk identification.
Area of Science:
- Obstetrics and Gynecology
- Maternal Health
- Healthcare Quality Improvement
Background:
- Obstetrical hemorrhage is a major cause of severe maternal morbidity and mortality.
- Existing hemorrhage risk scores are primarily linked to transfusion risk, with limited data on non-transfusion-related morbidity.
- The California Maternal Quality Care Collaborative (CMQCC) developed an admission hemorrhage risk score.
Purpose of the Study:
- To evaluate the association between the CMQCC admission hemorrhage risk score and severe maternal morbidity (SMM).
- To assess the score's predictive value for both transfusion-associated and non-transfusion-associated SMM.
- To determine if risk stratification aids in identifying patients at higher risk for adverse outcomes.
Main Methods:
- Retrospective cohort study of delivery admissions from 2018-2019 within a single healthcare network.
- Patients were stratified into low, medium, and high risk using the CMQCC criteria.
- Severe maternal morbidity was defined using ICD codes, ICU admission, or prolonged hospital stay; multivariable logistic regression analyzed the association with risk score.
Main Results:
- Overall SMM incidence was 2.4%; non-transfusion SMM was 0.6%.
- SMM incidence increased with risk strata: 1.6% (low), 2.5% (medium), and 13.6% (high risk) (P<.001).
- High-risk patients had significantly higher odds of SMM (aOR 8.8) and non-transfusion SMM (aOR 3.6).
Conclusions:
- The CMQCC hemorrhage risk score predicts both transfusion- and non-transfusion-associated severe maternal morbidity.
- High hemorrhage risk on admission is strongly associated with increased severe maternal morbidity.
- Risk identification alone may be insufficient; further interventions are needed to mitigate morbidity in high-risk patients.
Related Concept Videos
Hazard Ratio
For example, in a clinical trial...
Relative Risk

